日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharma association issues report on innovative drugs

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-04-21 17:44
Share
Share - WeChat
The Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment held an event on Tuesday to release a report on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative. [Photo provided to chinadaily.com.cn]

A total of 200 innovative drugs have been approved in China over the past five years, among which many have been included in public-funded medical insurance programs, according to a recent report by the Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment.

Focusing on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative, the report said about 33 percent of innovative drugs approved in the past five years are tumor treatments, and about 80 percent of the drugs, or 156 titles, are from multinational pharmaceutical companies.

The innovative drugs registered by multinational pharmaceutical companies have also showed more diversity in the past five years, as the share of tumor treatments has dropped to 33 percent from 47 percent in the period from 2010 to 2015, while more drugs for diseases related to the nervous system, digestion and the cardiovascular and respiratory systems have been registered.

Yang Ying, vice-president of Worldwide Business Development Asia at US-based pharmaceutical company Pfizer, said foreign pharmaceutical enterprises see China not only as an important market, but also an important investment destination for both commercialization and research and development.

As Chinese enterprises show increasing innovation capabilities, there are more cooperation opportunities for foreign and domestic enterprises in pharmaceutical industry, she said.

However, high costs and patients' lack of access to innovative drugs still remain a problem for the innovative pharmaceutical industry in China, according to the report.

Innovative drugs only account for about 9 percent of the total pharmaceutical market in China, the world's second-largest pharmaceutical market in the world, while in other G20 member countries the figure is all above 20 percent, and in developed countries such as the United States, Japan and Germany, the figure is more than 50 percent.

Kang Wei, managing director of RDPAC, suggested promoting the development of commercial insurance to increase the accessibility of innovative drugs and thus better meet Chinese patients' clinical demands.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 国产精品久久久久国产A级 首页亚洲国产丝袜长腿综合 | 中文字幕亚洲欧美日韩在线不卡 | 性大毛片视频 | www.久久久.com | 妞干网免费在线观看 | 三级国产精品一区二区 | 一级毛片ab片高清毛片 | 国产精品18hdxxxⅹ在线 | 国产精品无码人妻系列AV | 欧美日韩国产综合网 | 91高清网站 | 中国一级特黄毛片大片 | 欧美一区二 | av在线毛片| 亚州久久 | 欧美日韩精品久久久免费观看 | 女人被男人狂躁下面在线观看 | 国产一级毛片在线看 | 国产女人与拘做受视频 | 欧美人成片免费看视频不卡 | 亚洲欧美韩国日产综合在线 | 免费中文字幕视频 | 国产一级做a爰片在线 | 1级毛片 | 五月婷婷综合激情 | 看黄色一级视频 | 久久久一区二区三区不卡 | 一级黄a| 日本美女毛茸茸 | 欧美午夜精品一区二区蜜桃 | 日韩一区二区在线观看视频 | 久久久久久久国产 | 黄色一级毛片 | 成人1234| 污污成人一区二区三区四区 | 日韩中文字幕在线观看视频 | 久久久久欧美激情 | 男人天堂99 | 亚洲综合一二三区 | 久久精品视频99 | 久久狠狠|